Anzeige
Mehr »
Login
Sonntag, 19.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
GOLD-MINEN vor Jahrhundert-Hausse?! Diese Aktie sofort kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2N38G | ISIN: US29772L1089 | Ticker-Symbol:
NASDAQ
17.05.24
21:51 Uhr
3,625 US-Dollar
-0,010
-0,28 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
ETON PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
ETON PHARMACEUTICALS INC 5-Tage-Chart

Aktuelle News zur ETON PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
09.05.Eton Pharmaceuticals GAAP EPS of -$0.03, revenue of $8M1
09.05.Eton Pharmaceuticals, Inc. - 10-Q, Quarterly Report1
09.05.Eton Pharmaceuticals, Inc. - 8-K, Current Report1
08.05.Eton Pharmaceuticals Q1 2024 Earnings Preview1
01.05.Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference1
30.04.Eton Pharmaceuticals Announces NDA Submission For ET-4001
30.04.Eton Pharmaceuticals, Inc. - 8-K, Current Report1
30.04.Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)79- Company anticipates 10-month review for potential approval in Q1 2025 -- Eton expects ET-400 and Alkindi Sprinkle® to achieve potential combined peak sales of more than $50 million annually -- Product...
► Artikel lesen
29.04.Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 20241
18.04.Eton Pharmaceuticals, Inc. - 8-K, Current Report1
26.03.Eton Pharmaceuticals, Inc. - S-8, Securities to be offered to employees in employee benefit plans1
22.03.Eton Pharmaceuticals, Inc. - 10-K/A, Annual Report1
22.03.Eton Pharmaceuticals, Inc. - 8-K, Current Report2
22.03.Relief Therapeutics grants exclusive U.S. rights to Eton Pharmaceuticals for PKU GOLIKE3
22.03.Eton Pharma Buys U.S. Rights To PKU GOLIKE From Relief Therapeutics4
22.03.Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria1
22.03.Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE1.615Relief Therapeutics Holding SA / Key word(s): Partnership Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE 22-March-2024...
► Artikel lesen
15.03.Eton Pharmaceuticals, Inc. (ETON) Q4 2023 Earnings Call Transcript1
15.03.Earnings call: Eton Pharmaceuticals reports robust Q4 growth1
14.03.Eton Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary1
Seite:  Weiter >>
37 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1